|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,384.00 JPY | -2.99% |
|
-2.09% | +9.74% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-28 | Ono Pharmaceutical Co., Ltd. Partners with Phylo, Inc. to Embed Agentic AI with Every Discovery Scientist | CI |
| Market Cap | 1,120B 7.03B 6.11B 5.69B 5.22B 9.86B 671B 10.01B 67.05B 26.31B 334B 26.4B 25.82B | P/E 2027 * |
15.7x | P/E 2028 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 920B 5.77B 5.02B 4.67B 4.29B 8.1B 551B 8.22B 55.05B 21.61B 274B 21.68B 21.2B | EV / Sales 2027 * |
2.02x | EV / Sales 2028 * | 1.96x |
| Free-Float |
80.98% | Yield 2027 * |
3.29% | Yield 2028 * | 3.25% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -2.99% | ||
| 1 week | -2.09% | ||
| 1 month | -0.17% | ||
| 3 months | +3.38% | ||
| 6 months | +3.54% | ||
| Current year | +9.74% |
| 1 week | 2,324 |  | 2,514.5 |
| 1 month | 2,324 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | -2.09% | +41.02% | -8.36% | 7.03B | |
| -0.53% | +2.54% | +16.63% | +74.09% | 50.03B | |
| -1.81% | -0.49% | +51.99% | +112.44% | 36.6B | |
| +0.46% | +4.44% | -5.24% | +25.38% | 12.47B | |
| +1.05% | +1.63% | +16.19% | +78.22% | 11.77B | |
| -1.33% | -0.76% | +30.08% | +131.70% | 9.04B | |
| +0.51% | +1.46% | +12.17% | +32.88% | 6.79B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +1.99% | +1.91% | +4.68% | +183.54% | 6.6B | |
| -.--% | -1.95% | - | - | 5.73B | |
| Average | -0.26% | +0.70% | +20.94% | +78.74% | 15.28B | |
| Weighted average by Cap. | -0.60% | +1.15% | +25.18% | +82.84% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.85B 2.48B 2.31B 2.12B 4B 272B 4.06B 27.21B 10.68B 136B 10.72B 10.48B | 445B 2.79B 2.43B 2.26B 2.07B 3.91B 266B 3.97B 26.61B 10.44B 133B 10.48B 10.25B |
| Net income | 71.42B 448M 390M 363M 333M 629M 42.78B 638M 4.27B 1.68B 21.3B 1.68B 1.65B | 62.78B 394M 342M 319M 293M 553M 37.61B 561M 3.76B 1.47B 18.72B 1.48B 1.45B |
| Net Debt | -200B -1.26B -1.09B -1.02B -934M -1.76B -120B -1.79B -11.99B -4.71B -59.77B -4.72B -4.62B | -248B -1.56B -1.35B -1.26B -1.16B -2.18B -149B -2.22B -14.85B -5.83B -74.02B -5.85B -5.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | JP¥2,384.00 | -2.99% | 3,274,400 |
| 26-07-30 | JP¥2,457.50 | -1.36% | 1,852,100 |
| 26-07-29 | JP¥2,491.50 | +3.08% | 2,326,700 |
| 26-07-28 | JP¥2,417.00 | -0.92% | 1,462,400 |
| 26-07-27 | JP¥2,439.50 | +0.18% | 1,568,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
